<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anke Kohlenberg</style></author><author><style face="normal" font="default" size="100%">Olov Svartström</style></author><author><style face="normal" font="default" size="100%">Petra Apfalter</style></author><author><style face="normal" font="default" size="100%">Rainer Hartl</style></author><author><style face="normal" font="default" size="100%">Bogaerts, Pierre</style></author><author><style face="normal" font="default" size="100%">Huang, Te-Din</style></author><author><style face="normal" font="default" size="100%">Katerina Chudejova</style></author><author><style face="normal" font="default" size="100%">Lucia Malisova</style></author><author><style face="normal" font="default" size="100%">Jessica Eisfeld</style></author><author><style face="normal" font="default" size="100%">Mirco Sandfort</style></author><author><style face="normal" font="default" size="100%">Anette M Hammerum</style></author><author><style face="normal" font="default" size="100%">Louise Roer</style></author><author><style face="normal" font="default" size="100%">Kati Räisänen</style></author><author><style face="normal" font="default" size="100%">Laurent Dortet</style></author><author><style face="normal" font="default" size="100%">Rémy A Bonnin</style></author><author><style face="normal" font="default" size="100%">Tóth, Ákos</style></author><author><style face="normal" font="default" size="100%">Kinga Tóth</style></author><author><style face="normal" font="default" size="100%">Christina Clarke</style></author><author><style face="normal" font="default" size="100%">Martin Cormican</style></author><author><style face="normal" font="default" size="100%">Algirdas Griskevicius</style></author><author><style face="normal" font="default" size="100%">Kirstin Khonyongwa</style></author><author><style face="normal" font="default" size="100%">Marie Meo</style></author><author><style face="normal" font="default" size="100%">Niedre-Otomere, Baiba</style></author><author><style face="normal" font="default" size="100%">Reinis Vangravs</style></author><author><style face="normal" font="default" size="100%">Antoni Pa Hendrickx</style></author><author><style face="normal" font="default" size="100%">Daan W Notermans</style></author><author><style face="normal" font="default" size="100%">Samuelsen, Ørjan</style></author><author><style face="normal" font="default" size="100%">Manuela Caniça</style></author><author><style face="normal" font="default" size="100%">Vera Manageiro</style></author><author><style face="normal" font="default" size="100%">Vilhelm Müller</style></author><author><style face="normal" font="default" size="100%">Barbro Mäkitalo</style></author><author><style face="normal" font="default" size="100%">Urška Kramar</style></author><author><style face="normal" font="default" size="100%">Mateja Pirs</style></author><author><style face="normal" font="default" size="100%">Daniel Palm</style></author><author><style face="normal" font="default" size="100%">Dominique L Monnet</style></author><author><style face="normal" font="default" size="100%">Erik Alm</style></author><author><style face="normal" font="default" size="100%">Marius Linkevicius</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Emergence of  ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.</style></title><secondary-title><style face="normal" font="default" size="100%">Euro Surveill</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Bacterial Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">beta-Lactamases</style></keyword><keyword><style  face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style  face="normal" font="default" size="100%">Escherichia coli Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Escherichia coli Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">Europe</style></keyword><keyword><style  face="normal" font="default" size="100%">European Union</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style  face="normal" font="default" size="100%">Multilocus Sequence Typing</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2024 Nov</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">29</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Analysis of 594 isolates of sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. Most frequent were (n = 230) and (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying have increased rapidly since 2021. The increasing detection of carbapenemase genes in the high-risk lineage ST131 is a public health concern.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">47</style></issue></record></records></xml>